The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis (Q67710575)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

The potential of restricted T cell recognition of myelin basic protein epitopes in the therapy of multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

The Potential of Restricted T Cell Recognition of Myelin Basic Protein Epitopes in the Therapy of Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

9 November 2022

1 reference

history and philosophy of science

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

9 November 2022

1

D A Hafler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

author name string

M. Matsui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724362

9 November 2022

K. W. Wucherpfennig

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724362

9 November 2022

K. Ota

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724362

9 November 2022

H. L. Weiner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1724362

9 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

30 December 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1724362

full work available at URL

9 November 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1991.tb33456.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1991.tb33456.x/fullpdf

9 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Annals of the New York Academy of Sciences

9 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

251-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

MS: a CNS and systemic autoimmune disease

17 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

T cells responsive to myelin basic protein in patients with multiple sclerosis

9 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

The genetics of susceptibility to multiple sclerosis

9 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Multiple sclerosis and HLA DQw1

9 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

9 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

9 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

9 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis

9 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells

9 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis

9 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T-T cell interactions.

9 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

9 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein

9 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Frequency analysis of CD4+CD8+ T cells cloned with IL-4.

9 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

A study of the chemical nature of components of bovine white matter effective in producing allergic encephalomyelitis in the rabbit

9 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein

9 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Structure and diversity of the human T-cell receptor beta-chain variable region genes

9 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Sequences and diversity of human T cell receptor beta chain variable region genes

9 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain

9 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Diversity and structure of human T-cell receptor beta-chain variable region genes

9 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Sequences and repertoire of the human T cell receptor alpha and beta chain variable region genes in thymocytes

9 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Oligoclonal T lymphocytes in the cerebrospinal fluid of patients with multiple sclerosis

9 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity

9 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Conserved organization of the human and murine T-cell receptor beta-gene families

9 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention

9 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy

9 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized

9 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes

9 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis

9 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Characterization of a major encephalitogenic T cell epitope in SJL/J mice with synthetic oligopeptides of myelin basic protein

9 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

T cell determinants of myelin basic protein include a unique encephalitogenic I-E-restricted epitope for Lewis rats.

9 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis

9 November 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

9 November 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex

9 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

9 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Loss of functional suppression is linked to decreases in circulating suppressor inducer (CD4+ 2H4+) T cells in multiple sclerosis

9 November 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Decreased autologous mixed lymphocyte reaction in multiple sclerosis

9 November 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure

9 November 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1991.TB33456.X

9 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1724362%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference